PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 2010 March 1; 120(3): 653–656.
Published online 2010 February 22. doi:  10.1172/JCI42280
PMCID: PMC2827968

Bidirectional homing of Tregs between the skin and lymph nodes

Abstract

Although several homing receptors are known to be differentially expressed by Tregs in lymphoid tissues compared with those found in peripheral tissues, it remains unclear whether these cells traffic between the two locations. In this issue of the JCI, Tomura et al. report steady-state Treg migration from the skin to draining LNs in mice. Furthermore, they report that not only does skin inflammation exacerbate LN-directed Treg homing, it also triggers reverse circulation of Tregs from LNs to skin, whereby these cells contribute to regulation of the immune response. These results now form a new framework for our understanding of Treg homing.

Memory T cells are disseminated to lymphoid and nonlymphoid tissues throughout the body, and their migration to respective tissues is tightly regulated by adhesion molecules and chemokine receptors (Table (Table1).1). For example, memory T cells that infiltrate the skin express a unique adhesion molecule, known as cutaneous lymphocyte-associated antigen (CLA), which is produced from P-selectin glycoprotein ligand-1 through posttranscriptional carbohydrate modification by fucosyltransferase VII. Skin-homing memory T cells also express specific chemokine receptors: CCR4, CCR6, and CCR10. In contrast, memory T cells that preferentially circulate through lymphoid tissues express CD62 ligand (CD62L; also known as L-selectin) and CCR7 (1).

Table 1
Differential expression of homing receptors by skin-homing versus LN-homing memory T cells

Skin-resident Treg populations

The entire skin surface of an adult human is populated with approximately 2 × 1010 T cells, a majority of which express CLA, CCR4, and CCR6. Since approximately 1010 T cells circulate in peripheral blood, it has been estimated that normal skin contains twice as many T cells as are present in the blood circulation (2). Importantly, significant fractions (5%–20%) of those human skin–resident T cells appear to represent Tregs based on the phenotype of CD4+CD25hiCD69lo and the expression of Foxp3, a master transcriptional regulator of Treg development and function (2, 3). Conversely, large fractions of blood-circulating human Tregs express CLA (80%) and CCR6 (73%) (4). Thus, the skin, an outermost organ constantly exposed to external insults, appears to serve as a major site for the immunosuppressive action of Tregs. In fact, Foxp3-deficient scurfy mice develop autoimmune inflammatory lesions primarily in the skin and lung (5).

Analogous to homing mechanisms for memory T cells, adhesion molecules and chemokine receptors regulate tissue-specific trafficking of Tregs as well. A majority of Tregs found in secondary lymphoid tissues express CD62L and CCR7. In adoptive transfer experiments, Tregs isolated from CD62L-deficient mice were far less efficient than WT Tregs in their homing to peripheral LNs and spleen as well as in suppressing the onset of acute graft-versus-host disease (6). Likewise, adoptively transferred CCR7–/– Tregs failed to achieve LN-directed homing and, thus, to suppress antigen-specific proliferation of CD4+ naive T cells (7, 8). Similar observations have been made in NOD type 1 diabetes and cardiac allograft models (9, 10). Because CD62L–/– Tregs and CCR7–/– Tregs are both comparable to their WT counterparts with respect to their in vitro suppressive potentials, these observations imply that CD62L/CCR7-dependent homing of Tregs to secondary lymphoid tissues is required for their in vivo protective function.

A distinct Treg population expressing CD103 (also known as integrin αE) has been recently identified. These CD103+ Tregs are characterized by elevated expression of conventional memory T cell markers (e.g., CD44, CD54, CD29, and CD69) and selective migratory responses to inflammatory chemokines (11). Importantly, CD103 is expressed by skin-resident Tregs (which account for greater than 20% of CD4+ T cells in normal mouse skin), and its functional contribution has been demonstrated in antibody-blocking and CD103–/– Treg–transfer experiments (12, 13). Upon intradermal OVA injection, adoptively transferred, OVA-reactive CD103-CD62L+ Tregs acquired the expression of CD103, CCR4, and CLA, while losing CCR7 expression (12). Moreover, CCR4–/– Tregs and CLA–/– Tregs both exhibited impaired skin homing, signifying the equally important roles of this chemokine receptor and adhesion molecule (12, 14). The skin inflammation observed in the scurfy mouse is preventable by the transfer of WT Tregs, but not CLA–/– Tregs (15). Homing of Tregs to Leishmania major–infected skin lesions requires not only CCR4, but also CCR5 (16). Thus, Tregs expressing selected homing receptors preferentially migrate to the skin, where they presumably suppress the activation of effector T cells recognizing autoantigens or innocuous environmental antigens.

Direct tracking of Treg migration from the skin to draining LNs

As described above, Tregs employ distinct homing receptors for their preferential migration to lymphoid versus nonlymphoid epithelial tissues. A key question is whether Tregs are capable of trafficking between the two locations. In their current study in this issue of the JCI, Tomura et al. attempt to address this question by selectively “tagging” the skin-resident Tregs with the Kaede protein (17). Kaede (Acer palmatum, Japanese maple) decorates the autumn scenery by rapidly changing leaf color (Figure (Figure1).1). The leaf is green during the summer because of the presence of chlorophyll, which also masks other pigments such as carotenoids. In the fall, the leaf turns bright red because of protease-dependent degradation of chlorophyll and de novo synthesis of anthocyanins. Kaede protein, named after the Japanese maple because of the parallel color change, is one of the recently developed photoconvertible fluorescent proteins that change their emission spectra in response to light exposure. Cloned from a stony coral, Trachyphyllia geoffroyi, Kaede undergoes a green-to-red conversion within a few minutes after exposure to ultraviolet or violet light (18). Kaede protein contains an internal tripeptide, His62-Tyr63-Gly64, serving as a green-emitting chromophore like other GFP species, but undergoes unusual photocleavage at His62, thereby creating a new red-emitting chromophore (19). In Kaede-Tg mice, all the cell types constitutively exhibit Kaede-green fluorescence signals. Upon skin exposure to violet light, however, only those cells in the exposed skin begin to emit Kaede-red fluorescence signals.

Figure 1
The Kaede (Japanese maple) leaf changes color seasonally.

Tomura et al. report that 24 hours after exposure of the abdominal skin of Kaede-Tg mice to violet light, small numbers of Kaede-red cells became detectable in the draining axillary LNs, but not in nondraining cervical or popliteal LNs (17). This cell population was composed of roughly equal numbers of CD4+ T cells and CD11c+ DCs. Importantly, a significant fraction (approximately 20%) of Kaede-red CD4+ T cells expressed Foxp3, demonstrating steady-state trafficking of Tregs from the skin to draining LNs (Figure (Figure2A)2A) (17). To study skin-directed Treg homing further, the authors intercrossed the Kaede-Tg mice with Foxp3 reporter mice and then induced allergic contact dermatitis by sensitization with 2,4-dinitro-1-fluorobenzene (DNFB) on the dorsal skin, followed by DNFB challenge on the abdominal skin. The resulting inflammatory skin lesions were found to contain roughly 5-fold more Foxp3+ Tregs compared with control skin sites challenged with vehicle alone. An even more striking (~20-fold) increase was observed in the numbers of Kaede-red Foxp3+ Tregs in the axillary LNs, unveiling exacerbated Treg migration from inflamed skin to LNs (Figure (Figure2B).2B). As expected, those skin-derived Kaede-red Tregs expressed higher levels of CD103, CD44, CCR4, and CCR5 and lower levels of CD62L and CCR7, compared with the Kaede-green Treg counterparts in the same LNs. However, the difference observed between the two Treg populations was rather modest, perhaps reflecting a major limitation of the experimental system; that is, Kaede-green Treg populations contain not only LN-resident Tregs, but also skin-derived Tregs that have migrated from skin before violet light exposure. Nevertheless, the observations reported by Tomura et al. provide the first experimental evidence for the concept that CD103+CCR4+CCR5+ Tregs frequently observed in the skin are indeed capable of migrating to draining LNs.

Figure 2
Treg trafficking between the skin and draining LNs.

New questions

Normal human skin and mouse skin are both populated with large numbers of Tregs, and their numbers further increase under inflammatory conditions. What are the mechanisms for maintaining such a large pool of Tregs? Do they divide in situ? Although Tregs were classically regarded as anergic, based on their extremely low in vitro mitotic activities, recent in vivo experiments have revealed their striking proliferative potentials. CD44hiCD62Llo Treg populations, but not their CD44loCD62Lhi counterparts, constantly incorporate BrdU, a synthetic analog of thymidine, into newly synthesized DNA in lymphoid tissues (20). Even more profound BrdU incorporation has been observed in the Tregs infiltrating Leishmania major–infected skin lesions (21).

Do skin-derived Tregs found in the LNs migrate back to the skin? To test this, Tomura et al. (17) photoconverted the LN cells and tracked their subsequent trafficking. A majority of the Kaede-red Tregs disappeared from the light-exposed LN within 48 hours, indicating their rapid efflux. Strikingly, a small, but significant, number of Kaede-red Tregs became detectable in DNFB-induced contact hypersensitivity skin lesions, unveiling their previously unrecognized ability to reverse-traffic from LNs to inflammatory skin (Figure (Figure2C).2C). Do the adhesion molecules and chemokine receptors known to mediate Treg migration from the skin to LNs also facilitate reverse Treg trafficking? Alternatively, Tregs may switch their homing receptor expression profiles depending upon the direction of their trafficking. Indeed, Tregs have been reported to employ largely overlapping, but slightly distinct, sets of homing receptors for their trafficking from the blood circulation to peripheral tissues and for their subsequent migration to draining LNs (22).

In the absence of Tregs, DCs and CD4+ helper T cells form stable cell-cell contacts in an antigen-specific manner. Interestingly, Tregs interrupt this cell-cell contact formation by primarily interacting with DCs (23). Because not only Tregs, but also DCs, were reported by Tomura et al. to migrate spontaneously from the skin to draining LNs (Figure (Figure2A)2A) (17), it is tempting to speculate that those Tregs migrating from the skin may dampen the antigen-presenting capacity of the comigrating skin-derived DCs, thereby preventing the activation of autoreactive CD4+ helper T cells in the LNs. In this regard, dermal DCs, but not epidermal Langerhans cells, have been reported to simultaneously trigger the production of the proinflammatory cytokine IFN-γ by helper T cells and of the antiinflammatory cytokine IL-10 by Tregs (24).

In summary, Tomura et al. have uncovered a unique ability of Tregs to migrate back and forth between the skin and LNs (17). Their experimental system should serve as an extremely useful model for answering the above and other important questions regarding Treg homeostasis and function.

Acknowledgments

The authors are supported by NIH grants RO1-AI46755, RO1-AR35068, RO1-AR43777, and RO1-AI43232.

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Citation for this article: J Clin Invest. 2010;120(3):653–656. doi:10.1172/JCI42280

See the related article beginning on page 883.

References

1. Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol. 2009;9(3):153–161. doi: 10.1038/nri2496. [PubMed] [Cross Ref]
2. Clark RA, et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol. 2006;176(7):4431–4439. [PubMed]
3. Clark RA, et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med. 2008;205(10):2221–2234. doi: 10.1084/jem.20071190. [PMC free article] [PubMed] [Cross Ref]
4. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006;177(7):4488–4494. [PubMed]
5. Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci U S A. 2005;102(41):14735–14740. doi: 10.1073/pnas.0507014102. [PubMed] [Cross Ref]
6. Ermann J, et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood. 2005;105(5):2220–2226. doi: 10.1182/blood-2004-05-2044. [PubMed] [Cross Ref]
7. Kocks JR, Davalos-Misslitz AC, Hintzen G, Ohl L, Forster R. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. . J Exp Med. 2007;204(4):723–734. doi: 10.1084/jem.20061424. [PMC free article] [PubMed] [Cross Ref]
8. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med. 2007;204(4):735–745. doi: 10.1084/jem.20061405. [PMC free article] [PubMed] [Cross Ref]
9. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. . J Immunol. 2002;169(5):2461–2465. [PubMed]
10. Ochando JC, et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol. 2005;174(11):6993–7005. [PubMed]
11. Huehn J, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med. 2004;199(3):303–313. doi: 10.1084/jem.20031562. [PMC free article] [PubMed] [Cross Ref]
12. Sather BD, et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med. 2007;204(6):1335–1347. doi: 10.1084/jem.20070081. [PMC free article] [PubMed] [Cross Ref]
13. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol. 2005;174(9):5444–5455. [PubMed]
14. Siegmund K, et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood. 2005;106(9):3097–3104. doi: 10.1182/blood-2005-05-1864. [PubMed] [Cross Ref]
15. Dudda JC, Perdue N, Bachtanian E, Campbell DJ. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med. 2008;205(7):1559–1565. doi: 10.1084/jem.20072594. [PMC free article] [PubMed] [Cross Ref]
16. Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med. 2006;203(11):2451–2460. doi: 10.1084/jem.20060956. [PMC free article] [PubMed] [Cross Ref]
17. Tomura M, et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest. 2010;120(3):883–893. [PMC free article] [PubMed]
18. Ando R, Hama H, Yamamoto-Hino M, Mizuno H, Miyawaki A. An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein. Proc Natl Acad Sci U S A. 2002;99(20):12651–12656. doi: 10.1073/pnas.202320599. [PubMed] [Cross Ref]
19. Mizuno H, et al. Photo-induced peptide cleavage in the green-to-red conversion of a fluorescent protein. Mol Cell. 2003;12(4):1051–1058. doi: 10.1016/S1097-2765(03)00393-9. [PubMed] [Cross Ref]
20. Fisson S, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198(5):737–746. doi: 10.1084/jem.20030686. [PMC free article] [PubMed] [Cross Ref]
21. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med. 2006;203(3):777–788. doi: 10.1084/jem.20052056. [PMC free article] [PubMed] [Cross Ref]
22. Zhang N, et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. 2009;30(3):458–469. doi: 10.1016/j.immuni.2008.12.022. [PMC free article] [PubMed] [Cross Ref]
23. Tadokoro CE, et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med. 2006;203(3):505–511. doi: 10.1084/jem.20050783. [PMC free article] [PubMed] [Cross Ref]
24. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity. 2009;30(2):277–288. doi: 10.1016/j.immuni.2008.11.013. [PMC free article] [PubMed] [Cross Ref]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation